doi: 10.1016/S0140-6736(19)31150-X 135 HonigbergMCChangLSMcGuireDKPlutzkyJArodaVRVaduganathanM
"By bringing the API manufacturing domestic, we can control far more of the process end to end, giving us advantages in quality and purity and reliability and ultimately, in brand trust that I think will be incredibly difficult for others to match and I think increasingly important as these treatments and therapeutics become more mass market," Dudum said during the call
Recalls & Warnings January 21, 2018 Joint Supplement Recalled for Salmonella Risk On January 21, 2018, Arthri-D, LLC announced a recall of its joint pain supplement, Arthri-D (120 count), due to possible Salmonella contamination
It has been one of the most consistently studied peptides in research environments over the past two decades, examined for its interactions with vascular signaling networks, connective tissue pathways, and adaptive cellular communication
We believe in providing all the information necessary to ensure the successful application of our products in your research